Luo Pan P - OmicsDI

Show results for

Unknown (841)
Proteomics (28)
Metabolomics (21)
Transcriptomics (14)
Genomics (1)

Organisms

Schizophyllum commune H4-8 (14)
Mycobacterium tuberculosis SP7 (14)
Salmonella enterica subsp. enterica serovar Typhimurium str. T000240 (14)
Oryza sativa Japonica Group (14)
Rabbit calicivirus (14)
Crotalus durissus terrificus (14)
Eriocheir sinensis (14)
Candidatus Endoriftia persephonae (14)
Mycobacterium tuberculosis SP10 (14)
Mycobacterium tuberculosis SP13 (14)
Cotesia typhae (14)
Mycobacterium tuberculosis SP22 (14)
Cepaea nemoralis (14)
Enterobacter ludwigii (14)
Trichoderma asperellum CBS 433.97 (14)
Corynebacterium diphtheriae bv. mitis str. ISS 3319 (14)
Nakaseomyces glabratus (14)
Olea europaea (14)
Chlamydomonas reinhardtii (14)
Lama (14)
Planorbella pilsbryi (14)
Wolbachia sp. wMelPop (14)
Pyricularia oryzae P131 (14)
Homo sapiens (12)
Mus musculus (9)
Tardigrada (2)
Pan troglodytes (1)
Nicotiana tabacum (1)
Porphyromonas gingivalis W83 (1)
Bubalus bubalis (1)

Repository

MetaboLights (21)
biostudies-arrayexpress (15)
pride (14)
iProX (13)
MassIVE (1)

Tissue

Skin (3)
Liver (3)
Cell culture (3)
Keratinocyte (2)
Heart (2)
Blood serum (1)
Brain (1)
Hepatocyte (1)
Permanent cell line cell (1)

Disease

Wounds and Injuries (2)
Osteosarcoma (1)
COVID-19 (1)

Technology Type

Mass spectrometry (14)
Mass Spectrometry (14)
Mass spectrometry assay (6)
Shotgun proteomics (5)
Gel-based experiment (4)
Bottom-up proteomics (2)
Affinity purification coupled with mass spectrometry proteomics (2)
NMR spectroscopy (1)
Data-independent acquisition (1)
Data-dependent acquisition (1)
Top-down proteomics (1)

Instrument Platform

Liquid Chromatography MS - negative - hilic (8)
Liquid Chromatography MS - positive - hilic (8)
Liquid Chromatography MS - positive - reverse-phase (5)
Liquid Chromatography MS - negative - reverse-phase (5)
Liquid Chromatography MS - negative - reverse phase (4)
Liquid Chromatography MS - positive - reverse phase (4)
Liquid Chromatography MS - negative - HILIC (2)
Liquid Chromatography MS - positive - HILIC (2)
Qiagen RNAeasy, Bioanalyzer QubitFluorometer, Agilent 2100, RNA Pico 6000 chip (1)
DNBSEQ-G400 (1)
Illumina NovaSeq 6000 (1)
Q Exactive (1)
Gas Chromatography MS - positive (1)
Nuclear Magnetic Resonance (NMR) - (1)

Publication Date

2026 (12)
2025 (10)
2024 (8)
2023 (5)
2022 (5)
2013 (4)
2021 (4)
2014 (2)
2016 (1)
2015 (1)
2012 (1)
2011 (1)
2010 (1)
2009 (1)
2006 (1)
2018 (1)
2020 (1)

CHEBI ID

CHEBI:15891 (5)
CHEBI:16704 (5)
CHEBI:17568 (5)
CHEBI:17596 (5)
CHEBI:18257 (5)
CHEBI:17368 (5)
CHEBI:17191 (4)
CHEBI:48131 (4)
CHEBI:73722 (4)
CHEBI:16643 (4)
CHEBI:41865 (4)
CHEBI:16467 (4)
CHEBI:17351 (4)
CHEBI:35581 (4)
CHEBI:16359 (4)
CHEBI:18132 (4)
CHEBI:17361 (4)
CHEBI:17750 (4)
CHEBI:20067 (4)
CHEBI:16040 (4)
CHEBI:16027 (4)
CHEBI:16919 (4)
CHEBI:30915 (4)
CHEBI:16296 (3)
CHEBI:102265 (3)
CHEBI:17890 (3)
CHEBI:41254 (3)
CHEBI:25351 (3)
CHEBI:68641 (3)
CHEBI:32806 (3)

Metabolite Name

Adenosine (9)
Creatine (9)
Betaine (8)
Cytosine (8)
Hypoxanthine (8)
Guanine (8)
Creatinine (8)
Taurine (8)
Inosine (8)
Hexaethylene glycol (7)
7-Methylguanine (7)
Arginine (7)
Oleamide (7)
Glycerophosphocholine (7)
Adenine (7)
Acetophenone (6)
Pro-Ile (6)
Trigonelline (6)
Leucine (6)
Histidine (6)
Sphingosine (6)
Phe-Ala (6)
Pipecolic acid (6)
Leu-Val (6)
Uracil (6)
Citrulline (6)
Cytidine (6)
Iprovalicarb (5)
Crotonic Acid (5)
Dodemorph (5)

Study type

Transcription profiling by array (6)
RNA-seq of coding RNA (5)
Comparative genomic hybridization by array (1)
Other (1)
ChIP-seq (1)
RNA-seq of total RNA (1)

Release Date

2025 (145)
2022 (132)
2024 (117)
2023 (114)
2021 (88)
2020 (75)
2019 (40)
2018 (24)
2026 (18)
2015 (17)
2014 (17)
2016 (16)
2017 (16)
2013 (15)
2012 (6)
2011 (5)
2010 (3)
2009 (2)
2007 (2)
2006 (1)
2008 (1)
2005 (1)
2004 (1)

Lab affiliation

Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, 210042 Nanjing, China. (2)
Guangzhou Institute of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, 510623, China (1)
CAS Key Laboratory of Separation Sciences for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China (1)
Institute of Rocket Force Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, Third Military Medical University (Army Medical University) (1)
Department of Orthopaedics, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China (1)
Chengdu University of Traditional Chinese Medicine (1)
Helmholtz Munich (1)
Third Military Medical University (1)
Dermatology and Venereology Division, Department of Medicine (Solna), Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden (1)
Division of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (1)
Department of Microbiology, The University of Hong Kong, Hong Kong, SAR, China (1)
National Yang-Ming University Proteomics Research Center,Taiwan (1)
Shanghai Institute of Materia Medica (1)

Previous page
1 / 91
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 91
Next page

Sort by:

Relevance

Page size

Wen-Shen-Tong-Luo-Zhi-Tong Decoction regulates bone-fat balance in osteoporosis by adipocyte-derived exosomes.

Not available

S-EPMC10071966 | biostudies-literature

High-Coordination and Nb-Bridging of Bimetallic Amorphous P<sub>6</sub>-Nb-W-P<sub>5</sub> Clusters in Carbon Nanospheres for High-Performance Sodium-Ion Hybrid Capacitors.

Not available

S-EPMC11923884 | biostudies-literature

Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response.

Not available

S-EPMC9052621 | biostudies-literature

Clinical characteristics and prognostic implications of BRCA-associated tumors in males: a pan-tumor survey.

Not available

S-EPMC7556962 | biostudies-literature

Mass spectrometry-based proteomics reveals potential roles of NEK9 and MAP2K4 in resistance to PI3K inhibitors in triple negative breast cancer

Filip Mundt, Sandeep Rajput, Shunqiang Li, Kelly Ruggles, Arshag D. Mooradian, Philipp Mertins, Michael A. Gillette, Karsten Krug, et al., Cancer Res. 2018 May 15;78(10):2732-2746. doi: 10.1158/0008-5472.CAN-17-1990.

Activation of phosphoinositide 3-kinase (PI3K) signaling is frequently obs...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2018-10-19 | MSV000083050 | MassIVE

Comprehensive evaluation of the prevalent insulin resistance indices for pan-cancer incidence and mortality prediction.

Not available

S-EPMC12781529 | biostudies-literature

Gene expression Profiling in Follicular Lymphomas

Follicular lymphoma (FL) is an indolent, but incurable subtype of non-Hodgkin lymphoma. These tumor harbor t (14;18) translocation in at least 90% of patients. Recently, activating EZH2 mutations have been Follicular lymphoma (FL) is an indolent, but incurable subtype of non-Hodgkin lymphoma. These ...

ORGANISM(S): Homo sapiens

2014-07-01 | E-GEOD-55267 | biostudies-arrayexpress

Validation experiment for pan-sarcoma

the data of validation experiments for pan-sarcoma projects

ORGANISM(S): Homo Sapiens

2024-01-03 | PXD047429 |

Integration of transcriptional and epigenetic regulation of TFEB reveals its dual functional roles in Pan-cancer.

Not available

S-EPMC11567160 | biostudies-literature

Multiomics characteristics and immunotherapeutic potential of EZH2 in pan-cancer.

Not available

S-EPMC9842950 | biostudies-literature